174 related articles for article (PubMed ID: 24176050)
21. To explore preferences and willingness to pay for attributes regarding stoma appliances amongst patients in the UK, France and Germany.
Nafees B; Lloyd A; Elkin E; Porret T
Curr Med Res Opin; 2015 Apr; 31(4):687-95. PubMed ID: 25651482
[TBL] [Abstract][Full Text] [Related]
22. Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.
Jiang MZ; Fu Q; Xiong JY; Li XL; Jia EP; Peng YY; Shen X
BMC Health Serv Res; 2020 May; 20(1):430. PubMed ID: 32423447
[TBL] [Abstract][Full Text] [Related]
23. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
Patient; 2012; 5(1):33-44. PubMed ID: 22077619
[TBL] [Abstract][Full Text] [Related]
24. Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment.
Weymann D; Veenstra DL; Jarvik GP; Regier DA
Eur J Hum Genet; 2018 Sep; 26(9):1257-1265. PubMed ID: 29802320
[TBL] [Abstract][Full Text] [Related]
25. Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment.
Petrou S; McIntosh E
Value Health; 2009 Jun; 12(4):551-9. PubMed ID: 18798807
[TBL] [Abstract][Full Text] [Related]
26. Discrete choice experiment to derive willingness to pay for methyl aminolevulinate photodynamic therapy versus simple excision surgery in basal cell carcinoma.
Weston A; Fitzgerald P
Pharmacoeconomics; 2004; 22(18):1195-208. PubMed ID: 15606226
[TBL] [Abstract][Full Text] [Related]
27. The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments.
Webb EJD; Meads D; Eskytė I; Ford HL; Bekker HL; Chataway J; Pepper G; Marti J; Okan Y; Pavitt SH; Schmierer K; Manzano A
Patient; 2020 Oct; 13(5):583-597. PubMed ID: 32588337
[TBL] [Abstract][Full Text] [Related]
28. Assessing preferences for prevention versus treatment using willingness to pay.
Corso PS; Hammitt JK; Graham JD; Dicker RC; Goldie SJ
Med Decis Making; 2002; 22(5 Suppl):S92-101. PubMed ID: 12369235
[TBL] [Abstract][Full Text] [Related]
29. Patient preferences and willingness-to-pay for ADHD treatment with stimulants using discrete choice experiment (DCE) in Sweden, Denmark and Norway.
Glenngård AH; Hjelmgren J; Thomsen PH; Tvedten T
Nord J Psychiatry; 2013 Oct; 67(5):351-9. PubMed ID: 23245636
[TBL] [Abstract][Full Text] [Related]
30. Patient Preferences for Rescue Medications in the Treatment of Breakthrough Cancer Pain.
Wu D; Hua Y; Zhao Z; Huang X; Rao Q; Liu L; Xiao Y; Chen Q; Sun JL
J Pain Symptom Manage; 2022 Dec; 64(6):521-531. PubMed ID: 36002122
[TBL] [Abstract][Full Text] [Related]
31. Type 2 diabetes patients' preferences and willingness to pay for lifestyle programs: a discrete choice experiment.
Veldwijk J; Lambooij MS; van Gils PF; Struijs JN; Smit HA; de Wit GA
BMC Public Health; 2013 Nov; 13():1099. PubMed ID: 24289831
[TBL] [Abstract][Full Text] [Related]
32. Patient preferences for dry powder inhaler attributes in asthma and chronic obstructive pulmonary disease in France: a discrete choice experiment.
Hawken N; Torvinen S; Neine ME; Amri I; Toumi M; Aballéa S; Plich A; Roche N
BMC Pulm Med; 2017 Jul; 17(1):99. PubMed ID: 28683805
[TBL] [Abstract][Full Text] [Related]
33. Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice Experiment.
Buchanan J; Wordsworth S; Schuh A
Patient; 2016 Dec; 9(6):525-536. PubMed ID: 27167075
[TBL] [Abstract][Full Text] [Related]
34. Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment.
Veldwijk J; Johansson JV; Donkers B; de Bekker-Grob EW
Value Health; 2020 Jul; 23(7):945-952. PubMed ID: 32762997
[TBL] [Abstract][Full Text] [Related]
35. Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.
Johnson P; Bancroft T; Barron R; Legg J; Li X; Watson H; Naeim A; Watkins A; Marshall DA
Value Health; 2014 Jun; 17(4):380-9. PubMed ID: 24968998
[TBL] [Abstract][Full Text] [Related]
36. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia.
Snoswell CL; Whitty JA; Caffery LJ; Loescher LJ; Gillespie N; Janda M
J Telemed Telecare; 2018 Dec; 24(10):683-689. PubMed ID: 30343653
[TBL] [Abstract][Full Text] [Related]
37. Valuing the delivery of dental care: Heterogeneity in patients' preferences and willingness-to-pay for dental care attributes.
Sever I; Verbič M; Sever EK
J Dent; 2018 Feb; 69():93-101. PubMed ID: 29242040
[TBL] [Abstract][Full Text] [Related]
38. Willingness to Pay in Caregivers of Patients Affected by Schizophrenia.
Daltio CS; Attux C; Ferraz MB
J Ment Health Policy Econ; 2017 Mar; 20(1):3-10. PubMed ID: 28418833
[TBL] [Abstract][Full Text] [Related]
39. Estimating Attribute-Specific Willingness-to-Pay Values from a Health Care Contingent Valuation Study: A Best-Worst Choice Approach.
Sever I; Verbič M; Klaric Sever E
Appl Health Econ Health Policy; 2020 Feb; 18(1):97-107. PubMed ID: 31562593
[TBL] [Abstract][Full Text] [Related]
40. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
